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Abstract
NOD-like receptor (NLR) proteins (Nlrps) are cytosolic sensors responsible for detection of pathogen and danger-associated
molecular patterns through unknown mechanisms. Their activation in response to a wide range of intracellular danger
signals leads to formation of the inflammasome, caspase-1 activation, rapid programmed cell death (pyroptosis) and
maturation of IL-1b and IL-18. Anthrax lethal toxin (LT) induces the caspase-1-dependent pyroptosis of mouse and rat
macrophages isolated from certain inbred rodent strains through activation of the NOD-like receptor (NLR) Nlrp1
inflammasome. Here we show that LT cleaves rat Nlrp1 and this cleavage is required for toxin-induced inflammasome
activation, IL-1 b release, and macrophage pyroptosis. These results identify both a previously unrecognized mechanism of
activation of an NLR and a new, physiologically relevant protein substrate of LT.
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Introduction
Anthrax lethal toxin (LT) is a key virulence determinant of
Bacillus anthracis. This bipartite toxin consists of the receptor-
binding protein protective antigen (PA) and the metalloprotease
lethal factor (LF) [1]. LT injection into experimental animals
induces a vascular collapse similar to that occurring during
anthrax infections. LT also induces rapid lysis of macrophages
from certain inbred rodent strains, but macrophage lysis in vivo is
not essential for toxin-induced death of mice. LF’s only known
substrates are the mitogen-activated protein kinase kinases (MEKs
1, 2, 3, 4, 6 and 7). To date, no link between their cleavage and
macrophage lysis or animal death has been found [1].
LT induces death in certain inbred and outbred rat strains in as
little as 37 minutes [2,3]. We recently used recombinant inbred
rats to map the gene controlling LT sensitivity of both the rats and
their macrophages to a region of rat chromosome 10 encoding the
NOD-like receptor (NLR) Nlrp1 [3]. The Nlrp proteins are
pattern recognition receptors (PRRs) that act as cytoplasmic
sensors of danger signals ranging from dividing bacteria to
crystalline materials [4]. The activated sensors oligomerize and
recruit caspase-1 to a multiprotein complex (the inflammasome).
Inflammasome-mediated activation of caspase-1 allows it to cleave
the precursors of the inflammatory cytokines IL-1b and IL-18, as
well as currently unidentified substrates that cause the rapid lysis of
macrophages and dendritic cells (pyroptosis). Unlike other Nlrp
sensors that have been shown to be activated by a diverse set of
stimuli [4], Nlrp1’s only identified activator is LF. The mechanism
for activation has not yet been identified for any inflammasome
sensor. In this study we report that LF cleaves Nlrp1 and that
susceptibility of Nlrp1 to this cleavage dictates sensitivity of
macrophages to the pyroptosis induced by this toxin.
Results
Anthrax lethal toxin cleaves rat Nlrp1 from LT-sensitive
rats near the N-terminus
Our earlier studies found that polymorphisms within the N-
terminus of the rat Nlrp1 (rNlrp1) protein correlate perfectly with
LT sensitivity in twelve inbred rat strains [3]. The top two
sequences in Fig. 1 are rNlrp1 sequences which represent the
previously identified alleles associated with resistance or sensitivity.
The CDF Fischer rat (CDF) sequence represents Nlrp1 from LT-
sensitive rats (Nlrp1
S, abbreviated as S in Fig. 1). The Lewis rat
(LEW) sequence represents Nlrp1 from LT-resistant rats (Nlrp1
R,
abbreviated as R in Fig. 1). Residues 41–48 of the Nlrp1 from LT-
sensitive rats include 3 Arg and 2 Pro residues and are entirely
different from the largely hydrophobic residues in the correspond-
ing positions of the Nlrp1 of LT-resistant rats. The other 8 aa
differences between the resistant and sensitive Nlrp1 proteins from
12 inbred rat strains are distributed throughout the N-terminal
100 aa [3]. Notably, residues 41–48 of the Nlrp1 from LT-sensitive
rats fit consensus cleavage motifs of its MEK substrates [5–7]
(Fig. 1, top row shows one previously identified consensus motif
where the locations of basic (positively-charged) residues (B) and
hydrophobic residues (h) relative to the cleavage site are shown).
We hypothesized that LF cleaves Nlrp1 proteins at this site. Nlrp1
proteins are expressed at low levels and are difficult to detect.
Therefore we expressed full-length (1218 aa) N-terminally
hemagglutinin (HA) epitope-tagged rNlrp1
S (CDF), rNlrp1
R
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S and aa 54–1218 of rNlrp1
R (CDF53-LEW) and the
reciprocal construct (LEW53-CDF) (Fig. 1, lines 3,4) in HT1080
human fibroblasts. The proteins were expressed both transiently
and in stable lines selected for maximal expression. Western blots
and immunoprecipitation (IP) with anti-HA antibodies showed
expression of a full length HA-tagged rNlrp1 (140 kDa) in addition
to a shorter protein of about 110 kDa (Fig. 2a, 2b, 2c). This
smaller protein, which is often present in equal (data not shown) or
larger quantities (Fig. 2a, 2b, 2c) than the full-length rNlrp1,
probably results from autoproteolysis within the ZU5-UPA/FIND
domain that lies upstream of the CARD (caspase-1 recruitment)
domain [8]. LT treatment of fibroblasts expressing the HA-tagged
rNlrp1 proteins showed a small quantity of a 6-kDa HA-antibody
reactive fragment present in LT-treated CDF (Fig. 2a) and CDF-
LEW53 cells (data not shown), but not in LEW lines (Fig. 2a),
suggesting a possible cleavage event in proteins with rNlrp1
S
sequences at their N-termini. HT1080 cells expressing any of the
three Nlrp1 variants were all equally viable after the LF treatment
(data not shown). Cleavage of MEK3 confirmed that LF was active
within the cells under the conditions used (Fig. 2a). Direct LF
treatment of sucrose lysates of these cells showed loss of the HA-tag
from the full length and 110-kDa CDF and CDF53-LEW proteins,
but not from the LEW and LEW53-CDF proteins having N-
terminal rNlrp1
R sequences (Fig. 2b). Loss of HA western blot
reactivity from the 110-kDa proteins was consistent with cleavage
occurring within aa 1–53, and pointed to the 8-aa polymorphic
sequence as being the cleavage site. Anti-HA IP of the toxin-
treated lysates showed a single HA-tagged 6-kDa fragment
appearing coincidentally with loss of HA-epitope reactivity from
both the 140-kDa and 110-kDa rNlrp1 proteins, further
supporting the 8-aa sequence as the site of LF action (Fig. 2c).
HA-tagged rNlrp1
R (LEW) was not cleaved in response to LT
(Fig. 2c). An inactive LF variant (LF E687C) was unable to cleave
any of the proteins (data not shown).
To precisely identify the cleavage site, we expressed and purified
aa 3–100 of the rNlrp1
S (designated CDF100) as a fusion
containing an N-terminal 6His-GST tag (Fig. 1, line 7). This
CDF100 protein was cleaved efficiently even when using an
enzyme (LF): substrate (Nlrp1) molar ratio of 1:1000 (Fig. 3a).
Mass spectrometry analyses of the intact protein and the two
cleavage fragments yielded protein sizes of 39720, 33260, and
6478 Da (Fig. S1), showing that LF cleaved the Pro44-Leu45 bond
in the sequence RPRP‘LPRV of rNlrp1
S. Variants of the tagged
CDF100 protein in which the 2 or 4 aa immediately preceding the
LF cleavage site were changed to the corresponding rNlrp1
R
sequence (CDF100(EQ) and CDF100(QVEQ)) (Fig. 1, lines 8,9)
were also tested as substrates for LF or the enzymatically inactive
LF variant (LF E687C). LF E687C did not cleave any proteins
(Fig. 3b). CDF100(EQ) was cleaved by LF at a lower efficiency
than was CDF100 and CDF100(QVEQ) was not cleaved (Fig. 3b).
Thus, LF cleaves rNlrp1
S at a single site and the specificity of LF
for rNlrp1 depends at least in part on the aa sequence immediately
preceding the bond cleaved.
Anthrax lethal toxin cleavage of rat Nlrp1 is required for
inflammasome activation and pyroptotic macrophage
death
We next asked whether rNlrp1
S cleavage is required for LT-
mediated macrophage death. Functional inflammasomes contain-
ing various NLR proteins have previously been reconstituted in
non-macrophage cell lines such as HEK293 cells by expressing the
NLR proteins in conjunction with caspase-1 and using IL-1b as a
reporter for activation in response to stimuli. Expression of the
mouse paralog Nlrp1b and caspase-1 in HT1080 fibroblasts was
also shown to be sufficient for induction of approximately 30% cell
death following LT treatment [9]. However, we found that robust
transient or stable expression of rNlrp1
S in conjunction with rat
pro-caspase-1 in HT1080 (or CHO WTP4) cells did not sensitize
these cells to LT-mediated cell death (data not shown). Because
macrophages may express additional components needed for
induction of Nlrp1 inflammasome-mediated cell death, we
retrovirally expressed various rNlrp1 proteins in the LT-resistant
BMAJ mouse macrophage cell line. This cell line expresses the
mouse Nlrp1b
R protein. Expression of CDF53-LEW in the BMAJ
macrophages sensitized them to LT-induced cell death (Fig. 4a).
Expression of the CDF53-LEW protein containing the 2 aa
substitutions preceding the cleavage site (CDF53(EQ)-LEW)
resulted in partial sensitization, while substitution of 4 aa
(CDF53(QVEQ)-LEW abrogated sensitization (Fig. 4a). These
data strongly implicate the proteolytic cleavage of rNlrp1 by LF as
a key step in inflammasome activation and induction of pyroptosis
in macrophages. Coincident with cell death, there were equally
robust releases of IL-1b from the cells expressing either CDF53-
LEW or CDF53(EQ)-LEW (Fig. 4b), in spite of the weaker
sensitization of the latter to LT-induced cell death (Fig. 4a). This
indicates that there may be different efficiency and timing
requirements for the LT-induced caspase-1 activation events that
lead to cell death and to IL-1b processing. Supporting this
hypothesis, a recent report showed that a single stimulus can be
sensed by a single NLR, but activate distinctly different
inflammasomes, which activate caspase-1 through different
mechanisms [10].
Both mouse and rat Nlrp1 inflammasome activation and the
ensuing macrophage death in response to LT can be prevented by
a variety of treatments, including thermal shock [11], or inhibition
of caspase-1 [12–14], cathepsin B [14,15], and proteasome activity
[12,14,16]. These treatments all act downstream of LF endocytosis
and delivery to the cytosol, as evidenced by their failure to prevent
cleavage of the MEK substrates. We tested a panel of these
inhibitors for their abilities to protect BMAJ cells expressing
CDF53-LEW against LT-induced cell death and to prevent IL-1b
release. Protection was provided by nearly all the inhibitors
(Fig. 4c,d), the exceptions being the proteasome inhibitors, which
are usually highly protective against LT toxicity toward mouse
macrophage cell lines [12,14,16]. This poor protection may be
linked to the longer times (9–10 h) required to achieve complete
death of CDF53-LEW-expressing BMAJ cells compared to CDF
rat bone marrow-derived macrophages (which succumb in 3 h).
Author Summary
Anthrax lethal toxin (LT) is a protease which can induce
rapid death of macrophages accompanied by activation
and release of pro-inflammatory cytokines. The previously
identified cellular substrates for this toxin have not been
shown to play a role in this rapid cell death. This report
identifies a new substrate for LT, and demonstrates that its
cleavage by the toxin is required for macrophage death.
The substrate, Nlrp1, is a member of a large family of
intracellular sensors of danger. These sensors, once
activated, form a multiprotein complex called the inflam-
masome and are essential to the host innate immune
response. The mechanism of activation for these sensors is
not known. The demonstration of cleavage-mediated
activation of Nlrp1 in this study represents the first report
on a direct biochemical mechanism for inflammasome
activation.
Toxin Cleavage of Nlrp1 Activates the Inflammasome
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R in BMAJ cells likely
contributes to the slower death of the transformed cells.
Discussion
We present here data indicating that cleavage of rNlrp1 by
anthrax LT, in an N-terminal domain having no known function,
leads to inflammasome activation and macrophage death. This
represents the first report on biochemical modification of an
inflammasome sensor by a bacterial protein as a mechanism of
inflammasome activation. Recent reports demonstrate inflamma-
some activation mediated by binding of flagellin to NAIP sensor
proteins as a simple receptor-ligand activation mechanism that
allows for interaction of NAIP proteins with Nlrc4 and caspase-1
in a large oligomer [17,18]. It remains to be determined how
cleavage activates the Nlrp1 inflammasome. Cleavage may induce
conformational changes, further proteolytic/autoproteolytic
events, release from inhibitory proteins, or alteration in cytosolic
localization. Furthermore, it remains to be seen whether cleavage
of Nlrp1 directly activates the Nlrp1 inflammasome, or simply
allows for subsequent biochemical or cellular events that allow for
this sensor or another NLR to recruit and activate caspase-1.
Rodent Nlrp1 proteins differ from most NLRs in that they do
not contain a pyrin domain, a domain that is found at the N-
terminus of human Nlrp1. This pyrin domain is required for
association of NLR proteins with the scaffold protein, ASC, which
is required for caspase-1 autoproteolysis and IL-1b processing, but
not for caspase-1 mediated cell death [10]. The data presented
here raises the question whether mouse or human Nlrp1, or other
NLRs, can also be activated by LF through similar cleavage-based
mechanisms. Although mouse and human Nlrp1 proteins do not
contain the same sequence found in Nlrp1 of sensitive rats, it is
possible that LF can also cleave these proteins at a different site in
the N-terminal domain or elsewhere. Furthermore, one can
speculate that these and other NLR may be activated through
cleavage-based mechanisms by other cellular proteases responding
to the stimuli associated with inflammasome activation, or even by
a conformational change-mediated autoproteolytic event, in a
manner similar to caspase-1. An autoproteolytic capability of
Nlrp1 was recently reported [8], although a link between this
cleavage and inflammasome activation was not demonstrated. It
would not be surprising, however, if cleavage of Nlrp1 allowing
release of the CARD domain leads to constitutive activation of
caspase-1. Expression of the CARD domain of murine Nlrp1 has
been shown to result in constitutive caspase-1 activation [9], and
deletion of the leucine-rich repeat of Nlrc4 also leads to
constitutive caspase-1 activation [17].
This report also identifies a new LF substrate, distinct from the
only previously-identified physiologically relevant LF substrates,
the MEKs. Although the identification of a substrate with a role in
a cell death (i.e., pyroptotic) pathway now explains how the toxin
induces rapid macrophage lysis, a role for this pyroptosis in the
rapid rat death induced by LT remains to be elucidated.
An increasing number of bacterial virulence factors have been
identified which act catalytically to perturb normal cellular
processes. In some cases, the catalytic activity mimics activities
already present in the cell, as in the case of anthrax edema factor
adenylate cyclase, which produces an endogenous signaling
molecule, cAMP [19]. In other cases, the bacterial enzyme
catalyzes a reaction that inactivates a host process. In the case of
the LF-induced cleavage of NLR protein demonstrated here, it is
not yet clear whether this cleavage mimics a natural process of
inflammasome activation or whether it is an event with no parallel
in a normal process. Resolution of this question will come only
Figure 1. Comparison of the polymorphic regions of the rNlrp1constructs used in this study. The top two constructs represent the full-
length HA-tagged rNlrp1 proteins from the LT-sensitive rat (CDF) and the LT-resistant rat (LEW) used in this study. ‘‘S’’ denotes the rNlrp1
S sequence
and ‘‘R’’ denotes the rNlrp1
R sequence. The next four constructs represent chimeric proteins, and chimeric proteins in which mutations were made at
the putative LF cleavage site, (shown as a vertical dotted line below the filled arrow). These first six constructs were expressed as full-length proteins
in cells. The last three constructs represent proteins where aa 3–100 of rNlrp1were expressed and purified from E. coli as 6His-GST tagged proteins. In
the sequence alignments, residues identical to those in the construct listed above are indicated by quotations (’’). The residue at which fusion of the
CDF sequence to LEW or the LEW sequence to CDF occurs is shown with the open arrow. Grey shading denotes LEW sequence, while white denotes
CDF sequence. An LF consensus cleavage site motif is shown at the top, where B represents basic (positively-charged) residues and h stands for
hydrophobic residues – the position of each is shown relative to the cleavage site.
doi:10.1371/journal.ppat.1002638.g001
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inflammasome activation. As has occurred through the study of
other bacterial toxins, the further analysis of LF’s effects may aid in
deciphering the biochemical basis of a key cellular process - in this
case, inflammasome activation.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All bone
marrow harvests were from euthanized rats and were performed in
accordance to protocols approved by the NIAID Animal Care and
Use Committee (approved protocols OSD1, 3).
Materials
PA, LF, and LF E687C were purified from B. anthracis as
described previously [20]. Concentrations of LT correspond to the
concentration of each toxin component (i.e., 1 mg/ml LT has
1 mg/ml PA and 1 mg/ml LF). 6His-GST-fused rNlrp1 proteins
were expressed in plasmid pEX-N-His-GST (cat# PS100028,
Origene, Rockville, MD) and purified on glutathione-Sepharose
columns by standard methods. High affinity anti-HA (cat#
11867423001, Roche Diagnostics, Indianapolis, IN), anti-Mek3
(cat# sc-959, Santa Cruz BT, Santa Cruz, CA), anti-IL-1b (cat#
AF-401-NA, R&D Systems, Minneapolis, MN) and various IR-
dye conjugated secondary antibodies (Licor Biosciences, Lincoln,
NE and Rockland Immunochemicals, Gilbertsville, PA) were
purchased.
Cell culture and transfections
BMAJ mouse macrophages (gift of D. Radzioch), Phoenix 293T
(gift from Iain Fraser, NIAID, NIH), HT1080, and L929 cells
were cultured in Dulbecco’s Modified Eagle Medium (DMEM)
with 10% fetal bovine serum, 10 mM HEPES and 100 mg/ml
gentamicin (all obtained from Invitrogen, Carlsbad, CA) at 37uC
in 5% CO2. CHO WTP4 cells were grown in AMEM with the
same supplements. For certain experiments, cells were heat
shocked (42uC) for 1 h prior to toxin treatments. For all
transfections, endotoxin-free plasmid DNA was prepared (Endo-
Free Maxiprep, Qiagen, Valencia, CA) and cells were transfected
with TurboFect reagent (Fermentas, Glen Burnie, MD) according
to the manufacturer’s instructions. For transient transfections, cells
were treated with LT 24 h after transfection [3]. Transfected cells
were also lysed at the same time point in RIPA buffer and
subjected to Western blot (WB) analyses to verify expression of
rNlrp1, caspase-1 or IL-1b proteins, as previously described [12].
For stable transfections, HA-rNlrp1 overexpressing cell lines were
derived by selection with hygromycin B (500 mg/ml; Invitrogen)
for 12 days. High expressing clones were identified by Western
Figure 2. Cleavage of full length rNlrp1 by LF. (A) Treatment of
stably-transfected HT1080 cells overexpressing HA-tagged rNlrp1
proteins with LT (1 mg/ml) for 5 h followed by lysis and Western
blotting with anti-HA and anti-Mek3 antibodies. Full length and cleaved
HA-tagged rNlrp1 are shown. The central panel shows full length and
cleaved MEK3 (in a reprobing of the same gel). Cleavage of rNlrp1 leads
to appearance of the 6-kDa HA-reactive band. Cleavage of endogenous
MEK3 leads to a shift in mobility. (B) Sucrose lysates from stably-
transfected HT1080 cells overexpressing HA-tagged rNlrp1 proteins
were treated with LF (1 or 10 mg/ml) for 3 h, and subjected to Western
blotting with anti-HA (top row) or anti-MEK3 antibody (second row).
Cleavage of rNlrp1 leads to loss of the N-terminal HA epitope, and
cleavage of endogenous MEK3 leads to a shift in mobility. (C) IP (anti-
HA pulldown) followed by anti-HA Western blotting of lysates from
HT1080 cells expressing HA-tagged rNlrp1 following treatment with LF
(10 mg/ml, 3.5 h). Anti-HA reactive cross-reactive bands not marked as
HA-Nlrp1 also appear in vector-transfected controls (data not shown).
doi:10.1371/journal.ppat.1002638.g002
Figure 3. Cleavage of CDF100 by LF. (A) In vitro cleavage of N-
terminally 6His-GST-tagged aa 3–100 of rNlrp1
S (CDF100). Purified
protein (1 mg/ml) was treated with the indicated molar ratios of LF for
6 h prior to SDS gel electrophoresis and Coomasie staining. (B) 6His-
GST-tagged CDF100 protein or variants (1 mg/ml) were treated with
recombinant LF or enzymatically inactive LF E687C (each at 128 mg/ml)
for 3 h prior to SDS gel electrophoresis and Coomasie staining. F1 and
F2 refer to two fragments generated following LF treatment of CDF100
and its mutated variants.
doi:10.1371/journal.ppat.1002638.g003
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macrophages, Phoenix 293T packaging cells were transfected
first, as above and at 24 h, culture media were replaced with
DMEM. At 48 h, virus-containing media was removed, filtered
(0.45 mm membrane, Millipore, Billerica, MA) and supplemented
with polybrene at 10 mg/ml (Millipore) prior to incubation with
BMAJ macrophages. Virus-containing media were removed 24 h
later and replaced with DMEM. Stably-transfected cells were
selected over 2–3 weeks in the continuous presence of G418 sulfate
(500 mg/ml, Invitrogen). Bone marrow-derived macrophages
(BMDMs) used as a source of cDNA were obtained from rats
purchased from Charles River Laboratories (Wilmington, MA)
and cultured as previously described [12].
Constructs
cDNA was obtained from different rat strains by isolating RNA
from BMDMs [11,12,14]. To construct N-terminally hemagglu-
tinin (HA) tagged rNlrp1, an N-terminal HA tag was incorporated
into forward primers along with two restriction sites (59 NheI and
39 EcoRV- for primer table, see Table S1). For rNlrp1 from LT-
sensitive Fischer (CDF) and LT-resistant Lewis (LEW) rats, full
length rNlrp1 was amplified from CDF cDNA with Ex Taq
polymerase (TAKARA Bio Inc., Otsu, Japan) and TOPO TA
cloned into the pCR2.1-TOPO vector (Invitrogen). Full length
rNlrp1 was amplified from LEW cDNA with Phusion polymerase
(Finnzymes, Woburn, MA) and blunt-end TOPO cloned into the
pCR-Blunt II-TOPO vector (Invitrogen). NheI/EcoRV digested
fragments were ligated into the pIREShyg3 mammalian expres-
sion vector (Clontech, Mountain View, CA). CDF53-LEW- and
LEW53-CDF chimeric constructs were made by digestion of
CDF-pIREShygV3 and LEW-pIREShygV3 with XcmI/XbaI
(New England Biolabs, Ipswich, MA), gel purification of
fragments, followed by ligation to yield the appropriate fused
constructs. For retroviral expression, 59 BamHI and 39 NotI sites
were introduced into full length CDF53-LEW and LEW rNlrp1
amplified from CDF53-LEW-pIREShygV3 and LEW-pIRE-
ShygV3 using Phusion polymerase (New England Biolabs). PCR
products were cloned into the CloneJET vector (Fermentas) prior
to BamHI/NotI digestion and ligation into the pFB-NEO
retroviral vector (Agilent Technologies, Santa Clara, CA).
QuikChange (Agilent Technologies) was used to introduce 4 and
7 nucleotide changes into CDF53-LEW-pFB-NEO to create
CDF53(EQ)-LEW-pFB-NEO and CDF53(QVEQ)-LEW-pFB-
NEO. CDF100 was synthesized by Blue Heron Biotechnologies
(Bothell, WA) and cloned into the pEX-N-6HIS-GST vector using
AsiSI and AscI sites. The sequence of this construct differs from
the originally reported CDF rNlrp1sequence at one residue,
K61N, resulting in the rNlrp1
S allele 1 sequence [3]. The
QuikChange system (Agilent Technologies) was used to introduce
4 and 8 nucleotide changes. All clones were identified by
Figure 4. LT effects on cells expressing rNlrp1 constructs. (A) BMAJ cells (normally resistant to LT) that were retrovirally transfected with the
indicated rNlrp1 constructs were treated with LT (PA+LF) for 10 h. Percent viability was assessed by MTT staining and calculated relative to untreated
controls. Graph shown is from a single experiment, which is representative of eight identically performed experiments. Each point represents the
average of three wells. Insets show staining of representative sensitive and resistant cell lines following toxin treatment. (B) Supernatant levels of IL-
1b measured by ELISA. Cells were pretreated for 2 h with LPS (0.5–1 mg/ml), prior to LT treatment (7 h). Results shown are from a single experiment,
which is representative of three similar experiments. Each point represents the average of duplicate wells in this experiment. (C) Protection of the
sensitized BMAJ cell line transfected with rNlrp1fusion CDF53-LEW against challenge with LT (5 mg/ml) following treatment with 50 mM of each drug,
or heat shock. Results are average of three experiments, with duplicate wells per treatment in each experiment. (D) Average supernatant IL-1b levels
associated with protective treatments from (C) are shown. Results are the average of three experiments, with duplicate wells per treatment in each
experiment.
doi:10.1371/journal.ppat.1002638.g004
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ville, MD).
Western blots and immunoprecipitation
WB were performed using either anti-HA (1:1000), anti-
MEK3NT (1:500) or anti-IL-1b (1:2,500) and proteins were
detected using the Odyssey Infrared Imaging System (Licor
Biosciences) [11,12,14]. For immunoprecipitation (IP) experi-
ments, anti-HA antibody (Roche Diagnostics) was added to each
lysate sample (5–15 mg/ml) and samples were continuously mixed
by rotation at 4uC for 1 h. Protein A/G agarose (Santa Cruz
Biotechnology) was added, and samples were incubated at 4uC
overnight with rotation. Beads were centrifuged at 4,000 rpm for
2 min and washed with 10 mM HEPES three times prior to
elution of proteins using SDS loading buffer (10% SDS, 0.6 M
DTT, 30% glycerol, 0.012% bromophenol blue, at 90uC, 5 min).
Cleavage assays
To assess Nlrp1 cleavage in cell lysates, cells were grown to
confluence in 10-cm tissue culture dishes. For canonical cleavage,
cells in two confluent plates were treated with LT, detached by
trypsinization, washed 2 times (PBS, 1000 rpm for 5 min) and
lysed in 130 ml of sucrose buffer (250 mM sucrose, 10 mM
HEPES, 0.05 M EDTA, 0.2% Nonidet-P40) containing 5 ng/ml
LF inhibitor PT-168541-1 (gift of Alan Johnson, Panthera
Biopharma) followed by addition of 60 ml SDS loading buffer
(90uC, 5 min). For cleavage by LF treatment of pre-lysed cells, 5
confluent dishes were detached by trypsinization and washed 3
times (PBS, 1000 rpm for 5 min) and resuspended in 2.5 ml of
sucrose buffer (250 mM sucrose, 10 mM HEPES). Cells were
centrifuged (2500 rpm, 10 min), resuspended in 350 ml sucrose
buffer containing 0.2% Nonidet-P40 and incubated on ice 30 min.
All samples were extensively syringed by passage through a 29
gauge hub-less syringe (Terumo, Somerset, NJ) until .99% of all
cells were lysed. ZnCl2 and NaCl were added to final
concentrations of 1 mM and 5 mM, respectively. Lysates were
treated with LF for 3.5 h at 37uC. Cleavage was analyzed by WB
or IP/WB. For in vitro cleavage assays with purified proteins,
CDF100, CDF100(EQ) and CDF100(QVEQ) (at final concentra-
tions of 1 mg/ml were incubated in cleavage buffer (1 mM ZnCl2,
5 mM NaCl, 10 mM HEPES for 3 h at 37uC) with purified LF at
varying concentrations. Samples were separated on an 8–25%
SDS-PAGE gel using the PhastSystem (GE Life Sciences, Piscat-
away, NJ) and stained with Coomassie blue.
Toxicity and protection assays
All toxicity and protection assays were modified from methods
previously described [11,12,14] with minor modifications. Drugs
were tested over concentrations ranging from 0.1–100 mM and
were added 1 h prior to toxin (cathepsin B and caspase-1
inhibitors) or 5 h post-toxin (proteasome inhibitors) treatment.
LT treatment was performed with a concentration of 5 mg/ml
(9 h). Cell viability was assessed by staining with MTT [3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide] as previ-
ously described.
IL-1b measurements
Cells were pretreated with 0.5–1 mg/ml LPS (Calbiochem, San
Diego, CA) for 2 h prior to toxin treatment. LT was added for 7 h
at varying concentrations. Cytokine in culture supernatants was
measured using an IL-1b ELISA kit (R&D Systems) according to
the manufacturer’s instructions.
Mass spectrometry
The molecular masses of the H6-GST-LEW and CDF proteins
and their cleavage products were determined by liquid chroma-
tography-electrospray mass spectrometry using an HP/Agilent
1100 MSD instrument (Hewlett Packard, Palo Alto, CA) at the
NIDDK core facility, Bethesda, MD.
Supporting Information
Figure S1 Mass spectrometry analyses of cleavage products.
Mass spectrometry is shown for the three bands in gel representing
uncleaved CDF100 (A), and two cleavage products (B, C).
(DOC)
Table S1 Primers used in this study.
(DOC)
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